ENOVIX (ENVX)
$8.59
0.46 (5.30%)
ENVX Stock Quote Delayed 30 Minutes
What Are the Hottest Meme Stocks Right Now? 3 Top Picks.
Meme stocks – just mentioning the concept might cause eyes to roll. And that to be fair is a natural reaction. We’re all too familiar…
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:
Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
$9.63
Market Cap
1.72B
PE Ratio
-6.76
EPS
-1.2695
Volume (Avg. Vol.)
5.15M
Day's Range
$9.01 - $9.81
52-Week Range
$5.70 - $18.68
Dividend & Yield
N/A (N/A)
ENVX Stock Predictions, Articles, and ENOVIX News
Wall Street Favorites: 3 Under-$20 Stocks With Strong Buy Ratings for June 2024
These strong buy stocks under $20 offer long-term upside potential and each has Wall Street's stamp of approval.
Wall Street Favorites: 3 Lithium Stocks With Strong Buy Ratings for June 2024
Discover strong buy lithium stocks positioned for explosive growth in 2024 as they capitalize on surging demand and technological progress.
Small-Cap Sorcerers: 3 Stocks Conjuring Up Magical Returns from Humble Beginnings
Discover three small-cap stocks that will cast a spell on your portfolio with their substantial growth potential.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
Pre-market stock movers are worth checking out with our coverage of all the latest and greatest news happening on Thursday!
ENVX Stock Earnings: Enovix Misses EPS, Beats Revenue for Q1 2024
ENVX stock results show that Enovix missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024.
7 Non-Pharma Penny Stocks on the Brink of 100% Gains
Non-pharma penny stocks don't receive as much attention as biotech firms but they're every bit as valuable in many cases.
